Articles in section Licensing

<< Joint Venture

540 articles

Mergers & Acquisitions >>

<< Previous

Pages 1 ..49 50 51 52 53 54

Next >>

Pfizer Licenses Phase III AMD Drug from Eyetech Published: 3 Jan-2003
By: Business Review Editor
Abstract Fulltext:
Volume: 2003 Issue: 32
CeNeS Licenses MS Treatment to Acorda Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:
Volume: 2002 Issue: 31
Roche Secured Option on Antisoma Pipeline Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:
Volume: 2002 Issue: 31
AlphaRx to License Anticancer Toxin from Select Therapeutics Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:
Volume: 2002 Issue: 31
Allergan Licenses Phase I Skin Cancer Drug from Peplin Published: 2 Dec-2002
By: Business Review Editor
Abstract Fulltext:
Volume: 2002 Issue: 31
GSK Licenses Phase II Compounds from Exelixis Published: 2 Nov-2002
By: Business Review Editor
Abstract Fulltext:
Volume: 2002 Issue: 30
GeneSoft Licenses Rights to Factive from LG Life Sciences Published: 2 Nov-2002
By: Business Review Editor
Abstract Fulltext:
Volume: 2002 Issue: 30
Merck KGaA Licenses Niaspan and Advicor from Kos Published: 2 Nov-2002
By: Business Review Editor
Abstract Fulltext:
Volume: 2002 Issue: 30
GSK Licenses SGLT2-inhibitor from Kissei Published: 2 Nov-2002
By: Business Review Editor
Abstract Fulltext:
Volume: 2002 Issue: 30
KS Biomedix Secures European Deal Over TransMID™-R Published: 2 Oct-2002
By: Business Review Editor
Abstract Fulltext:
Volume: 2002 Issue: 29

Login

Username:

Password:

Keep me logged in